Alicja Urbaniak: Targeting CD148 for Novel Antithrombotic Therapy
Alicja Urbaniak, Instructor at UAMS – University of Arkansas for Medical Sciences, Full Member Cancer Therapeutics Program at The Winthrop P. Rockefeller Cancer Institute at UAMS, Chair of the Partnerships Committee at American Society for Pharmacology and Experimental Therapeutics – ASPET, shared a post on LinkedIn about a recent article by Lina El Badaoui et al, published in BPS Journal, adding:
“The article ‘Targeting CD148 for Antithrombotic Therapy: Functional and Molecular Evaluation of AKB 9778,’ recently published in Pharmacology Research and Perspectives, explores AKB 9778 (razuprotafib) and its potential to inhibit CD148, a protein tyrosine phosphatase involved in platelet activation. AKB 9778 partially inhibited thrombus formation in an in vitro whole blood model.
Molecular docking and mutagenesis helped identify residues involved in its interaction with CD148. However, its potency against CD148 was substantially lower than previously reported, highlighting the need for further characterization and optimization.
These findings suggest that AKB 9778 could serve as a starting point for developing more selective and effective CD148 inhibitors.
While this early stage research offers a promising direction for antithrombotic drug discovery, clinical efficacy and the potential for a lower bleeding risk remain to be established.”
Title: Targeting CD148 for Antithrombotic Therapy: Functional and Molecular Evaluation of AKB-9778
Authors: Lina El Badaoui, Stipo Jurcevic, Yotis A. Senis, Alastair J. Barr
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 4, 2026, 06:12David McIntosh: 900 Plasma Donations One Patient One Lifeline
-
Oct 4, 2026, 06:00Aadil Sheikh: Menopausal Hormone Therapy and Thrombosis Rethinking Route Dose and Risk
-
Oct 4, 2026, 05:27Nirali Thakkar: Influenza and Myocardial Infarction An Unexpected Cardiovascular Connection
-
Oct 4, 2026, 05:03Hisham Fahmi: Thromboprophylaxis in Children With ALL A Risk Adapted Approach
-
Oct 4, 2026, 05:00Mary Cushman: Erin Michos Highlights Rising Heart Disease Mortality Among Younger Women in the US
-
Oct 4, 2026, 04:48Liv Tybjærg Nordestgaard: Is Fasting Necessary Before Blood Sampling?
-
Oct 4, 2026, 04:31Sonal Sonu: Gen Z doesn’t just set trends – Gen Z saves lives
-
Oct 4, 2026, 04:22Registration Opens for 2027 Highlights of ASH – American Society of Hematology
-
Oct 4, 2026, 04:06Konstantinos Stavroulakis: Vessel Preparation in Lower Limb Revascularization